ICC International Cannabis Announces BIDIOL Distribution Deal

ICC International Cannabis (TSXV:ICC) announced a presale agreement with Brasliv through their import and export for a term of three years.
As quoted in the press release:

Brasliv is a Brazilian company based in Curitiba, Brazil and is focused on international commerce with a specialization in medical products. Brasliv has a reputation for efficiency and transparency when managing the international transport of goods and dealing with the required certifications and customs union procedures. Brasliv has been working with the Brazilian Health Regulatory Agency (Agência Nacional de Vigilância Sanitária or “ANVISA“) for more than two years in order to obtain the requisite import permits for cannabidiol (“CBD“) products such as ICC’s newly launched, proprietary line of CBD oil branded ‘BIDIOL’. Brasliv expects to receive authorizations for such imports by mid-2018.
Subject to ICC and Brasliv entering into a definitive agreement, and in accordance with the Agreement, Brasliv will purchase a minimum of 180,000 thirty millilitre bottles of BIDIOL per year for distribution for medicinal purposes.
In January 2017, the Brazilian health regulator, ANVISA, legalized the importation of cannabis-based products for medicinal purposes. Under Brazil’s regulatory regime, these products require a prescription.

Click here to read the full press release.